Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 70069-860

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 70069-860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

180's Count (180s Count)

Label for Acamprosate Calcium delayed-release tablets, 333 mg strength, containing 180 tablets. The label includes storage instructions, dosage information references, and manufacturer details for Somerset Therapeutics, LLC. It also features a barcode and a red NVZ marking.*

FDA Label Image

30's Count (30s Count)

Label for Acamprosate Calcium Delayed-Release Tablets, 333 mg strength, containing 30 tablets. The label includes manufacturer information for Somerset Therapeutics, LLC, storage instructions, dosage details, and a barcode. The product is indicated as Rx only and made in India.*

FDA Label Image

Acamprosate-spl-structure (Acamprosate Spl Structure)

Chemical structure of acamprosate calcium, showing the molecular arrangement including calcium ions complexed with the compound. The structure depicts functional groups relevant to the chemical identity of acamprosate calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.